Although islet transplantation is a promising therapeutic option for the treatment of type 1 diabetes, the shortage of suitable donor tissues remains a major obstacle. Pancreatic stem/progenitor cells residing within the ductal epithelium have been used to generate human islet-like clusters, but there is no efficient strategy for facilitating differentiation of progenitor cells into insulin-producing cells. A previous study reported that exogenous PDX-1 protein can be transduced into pancreatic stem/progenitor cells and induce differentiation of the cells into insulin-producing cells without requiring gene transfer technology. This study provides genetic and biochemical evidence that cell membrane heparan sulfate proteoglycans are required for extracellular PDX-1 internalization. Heparin, one of the soluble glycosaminoglycans (GAGs), inhibited PDX-1 internalization, while chondroitin sulfate A, B, and C caused only very limited inhibition. Cell treatment with heparinase-III demonstrated impaired PDX-1 internalization, while treatment with chondroitinase ABC, or with chondroitinase AC, was completely ineffective in inhibiting PDX-1 internalization. Different mutant cell lines originating from CHO K1 cells and defective in GAG biosynthesis were also examined. PDX-1 internalization was significantly reduced in both pgs A-745 mutant cells, which are defective in a enzyme that initiates GAG synthesis, and pgs B-618 cells, which produce about 15% of the amount of GAGs synthesized by wild-type cells. These data indicate that cell-surface heparan sulfate proteoglycans are required for PDX-1 internalization and that PDX-1 protein transduction could be a valuable strategy for inducing insulin expression in pancreatic stem/progenitor cells without requiring gene transfer technology.
INTRODUCTION
transcription (11, 12, 16, 26) . Even in adults, PDX-1 is associated with islet neogenesis and differentiation of insulin-producing cells from progenitor cells (2,6). A pre-Islet transplantation is a promising therapeutic option for the treatment of type 1 diabetes (10, 29, 33) . However, vious study reported that purified PDX-1 protein can be transduced into cells and that the 16 amino acids of the shortage of suitable donor tissues remains a major obstacle. Pancreatic stem/progenitor cells residing within PDX-1 (Fig. 1A) form a protein transduction domain (PTD) (19, 20, 22) . The transduced PDX-1 functions sim-the ductal epithelium have been used to generate human islet-like clusters (2), but there is no efficient strategy ilarly to endogenous PDX-1. It binds to the insulin promoter, PDX-1 itself, and several other β-cell genes, and for facilitating differentiation of progenitor cells into insulin-producing cells. Homeoproteins are transcription activates their expression. PDX-1 protein penetrated the cells by macropinocytosis and was released from endo-factors involved in the specification of cell type and differentiation during development. Pancreatic and duode-somes homogeneously in the cytoplasm and nuclei (20, 22) . These data suggest that PDX-1 protein transduction nal homeobox factor-1 (PDX-1) is a homeodomaincontaining transcription factor that plays a central role could be a safe and valuable strategy for facilitating differentiation of progenitor cells into insulin-producing in regulating pancreatic development and insulin gene 92 UEDA ET AL.
Construction of Vectors and Purification of Recombinant PDX-1 Proteins
Full-length PDX-1 cDNA was amplified by PCR using appropriate linker primers and then subcloned into the NdeI and XhoI sites of pET21a(+) (Novagen, Madison, WI) using a ligation kit (TaKaRa, Tokyo, Japan). BL21 (DE3) cells containing the expression plasmids were grown at 37°C to an OD 600 of 0.8. Isopropyl-Dthiogalactopyranoside was added to a final concentration of 0.1 mM, and then the cells were incubated for 12 h at 24°C. Cells were sonicated, and the supernatants were recovered and applied to a column of Ni-NTA agarose (Invitrogen, San Diego, CA).
Cell Lines
Wild-type CHO K1 and CHO K1 mutants deficient in proteoglycan biosynthesis (30) were obtained from the American Type Culture Collection (Manassas, VA). The pgs A-745 cell line does not produce detectable levels of proteoglycans because it lacks xylosyltransferase, an enzyme necessary for the initiation of glycosamino- (11, 26) , β-cell differentiation (2,6), and maintenance of cosa (500 U/ml); chondroitin sulfate A, from bovine tranormal β-cell function (8, 34, 37) . chea (500 µg/ml, Calbiochem, Germany); chondroitin A series of PTDs has been shown to mediate the resulfate B, from porcine intestinal mucosa (500 µg/ml); markable delivery of proteins into many mammalian tisand chondroitin sulfate C, from shark cartilage (500 µg/ sues. These PTDs are arginine-and lysine-rich sequences ml, Sigma, Japan)] and dextran sulfate [molecular weight, (21, 23, 24) . Recently, it was shown that cell membrane 5,000 (100 µg/ml, Wako, Japan)] were used in this exheparan sulfate proteoglycans (HSPs) ( Fig. 1B ) act as periment. In FACS experiments with soluble GAG anareceptors for extracellular TAT uptake (36) . Cells genetlogues, 5 × 10 5 CHO K1 cells were incubated in fresh ically defective in the biosynthesis of fully sulfated heculture medium with the addition of 10 µM PDX-1 PTD paran sulfate are selectively impaired in the internalizaand the appropriate amount of GAG dissolved in PBS. tion of recombinant TAT fused to green fluorescent After 1 h, the cells were washed four times with PBS, protein. The ubiquitous distribution of HSPs is consistrypsinized, and again washed with PBS. A total of tent with the efficient intracellular delivery of heterolo-10,000 cells were analyzed using FACSAria (Becton gous proteins fused with TAT to different mammalian Dickinson, Franklin Lakes, NJ). Each experimental cell types. point was performed in triplicate. This study demonstrates that cell membrane HSPs are Inhibition of PDX-1 Transactivation by GAG Lyases required for PDX-1 internalization.
A rat insulin II promoter-reporter (luciferase) plasmid
MATERIALS AND METHODS
(1.0 µg) containing 238-bp 5′-flanking sequences of the FITC-Conjugated PDX-1 PTD rat insulin II promoter region (19) was transfected into CHO K1 cells with LipofectAMINE (Invitrogen, Carls-Fluorescein isothiocyanate (FITC)-conjugated PDX-1 PTD peptide was synthesized by Sigma Genosys-Japan. bad, CA) using the conditions recommended by the manufacturer. Twenty-four hours after transfection, en-The peptide, purified by preparative reversed-phase HPLC, was >95% pure as analyzed by HPLC, and had the ex-zymatic treatment with GAG lyases was performed as previously described (35). Briefly, 5 × 10 5 CHO K1 pected amino acid composition and mass spectra. cells were incubated with GAG lyases (Sigma; dissolved pression ϳ5 h after the addition of exogenous GST-Tat protein to the culture medium (36) . The entry of PDX-in PBS) in PBS for 40 min at 37°C in a CO 2 incubator. Cells were then washed gently six times with PBS and 1 into the cells was also directly observed by labeling the PDX-1 PTD with FITC and then the treated cells incubated in conventional medium in the presence of 10 µM PDX-1 for 6 h. After this time, cells were washed were analyzed by flow cytometry. Figure 2B demonstrates that the PDX-1 PTD was rapidly internalized, four times with PBS. Luciferase assays (Promega, Madison, WI) were performed according to the manufactur-reaching significant intracellular levels 2 h after its addition to the medium. At each time point, the relatively er's protocols and after normalization for transfection efficiency. Each experimental point was performed in narrow FACS peak width indicates the uniform uptake of exogenous PDX-1 by all exposed cells. As previously triplicate.
described (22), the PDX-1 PTD was observed inside the PDX-1 Transduction Assays Using Cell Mutants cells with a distribution compatible with its presence inside endosomal vesicles after 30 min (data not shown). CHO K1 or mutant cells (5 × 10 5 ) were incubated in conventional medium in the presence of 10 µM PDX-1 At 90 min, the fluorescent signal was observed in the nuclei of some cells, consistent with the transactivating PTD for 1 h. The cells were then washed four times with PBS, trypsinized, washed again with PBS, resus-activity of the protein at this time point ( Fig. 2A ). Contrary to the full-length PDX-1 protein, treatment of cells pended, and used for FACS analysis. Each experimental point was performed in triplicate.
with PTD-deleted PDX-1 protein for 24 h did not result in any internalization of this protein nor in insulin trans-RESULTS activation (data not shown).
Kinetics of Extracellular PDX-1 Internalization
Effect of Soluble GAGs on PDX-1 Internalization The kinetics of insulin transactivation by extracellular PDX-1 protein is shown in Figure 2A . Insulin trans-Earlier studies indicate that cellular entry and HIV-1-LTR transactivation activity of exogenous TAT are in-activation was observed a few hours after the addition of PDX-1 to the culture medium of CHO K1 cells and hibited by heparin and that heparin-TAT interaction involves the basic domain of TAT (14, 31) . Heparin is a peaked at 6-12 h. These data are consistent with previous findings showing a peak of LTR-CAT mRNA ex-close structural homologue of heparan sulfate GAG, a major constituent of cell surface and extracellular matrix the charge distribution of the heparin chain play an essential role in PDX-1 interaction. proteoglycans (38). This suggests that heparin could compete with cell surface heparan sulfate proteoglycans Effect of GAG Lyases on PDX-1 Internalization for binding to TAT, as observed for other heparin binding growth factors. Next, the possibility that heparin and A large body of evidence indicates that cell surface heparan sulfate proteoglycans are rapidly internalized other soluble GAGs could inhibit PDX-1 internalization was tested. CHO K1 cells were incubated with FITC through an endocytic pathway and may directly internalize ligands that bind to their GAG chains. Such a mecha-PDX-1 PTD in the presence of different GAGs, and internalization of the fluorescent protein was visualized by nism has already been described for other heparan sulfate proteoglycan ligands, including TAT, basic fibroblast flow cytometry. As shown in Figure 3 , heparin almost completely prevented PDX-1 entry. In contrast, chon-growth factor, bacteria, and animal viruses (30,38). To determine whether this was also the case for PDX-1, droitin sulfate A, chondroitin sulfate B (dermatan sulfate), and chondroitin sulfate C caused a very limited PDX-1 internalization was studied after removal of different cell surface GAGs by specific lyases. CHO K1 inhibition.
GAGs are characterized by differences in their den-cells were treated with several enzymes for 40 min, incubated with the PDX-1 protein, and analyzed 6 h later sity of negative charge and saccharide composition. To determine whether inhibition of PDX-1 entry by heparin by flow cytometry to assess the amount of intracellular fluorescence. Cell treatment with heparitinase (heparin-depends on specific structural requirements of the GAG chain or simply by its ionic charge, competitive inhibi-ase-III), an enzyme that acts primarily on heparan sulfate (36), impaired PDX-1 internalization. Treatments tion studies were also performed using dextran sulfate, a homogeneous highly sulfated polysaccharide. Dextran with chondroitinase ABC, cleaving at a linkage found in all chondroitin sulfates including dermatan sulfate sulfate caused weak inhibition of PDX-1 internalization (Fig. 3) , indicating that both saccharide composition and (chondroitin sulfate B), or with chondroitinase AC, di- gesting specifically chondroitin sulfates A and C, were tion mechanism of antimicrobial peptides (15, 39) . The model proposes the interaction of the peptide with the completely ineffective in inhibiting PDX-1 internalization ( Fig. 4) . membrane, followed by displacement of lipids, alteration of membrane structure, and entry of the peptide PDX-1 Transduction Assays Using Cell Mutants into the interior of the target cell. PDX-1 PTD has simi-Taken together, the previous observations indicate lar structure to the antimicrobial peptides. This mechathat the interaction between PDX-1 and heparin/heparan nism would allow efficient passage of hydrophilic carsulfate is specific and suggests a role for cell surface goes, but would also be a threat to cell survival. Neither heparan sulfate proteoglycans in PDX-1 uptake. To pro-PDX-1 PTD nor full-length PDX-1 protein induces cell vide final genetic proof that cell surface heparan sulfate death. Moreover, the mechanism is for the internalizaproteoglycans act as major receptors for PDX-1 internaltion of peptide but not protein. Therefore, such a mechaization, different mutant cell lines originating from CHO nism is unlikely to be a common PTD delivery mecha-K1 cells and defective in GAG biosynthesis were ananism. A second model proposes that peptides bind to the lyzed (4,5,30). Wild-type and mutant cells were treated polar heads of lipids in the membrane through electroby the addition of PDX-1 PTD to the cell culture mestatic interaction, resulting in transient formation of indium, and cellular fluorescence was analyzed by flow verted micelles that engulf the peptide and its cargo, cytometry (Fig. 5 ). PTD internalization was clearly deeven at 4°C. Some experiments suggest that Antp-PTD tectable in wild-type CHO K1 cells. In contrast, the PTD (similar to PDX-1 PTD) might use this pathway. The entry significantly decreased in pgs A-745 mutant cells, addition of Antp-PTD to a film of brain lipids induces which are defective in an enzyme that initiates GAG the formation of inverted micelles (1). However, insynthesis, and pgs B-618 cells, which produce about verted micelle formation would limit the cargo size and 15% of the amount of GAGs synthesized by wild-type require the presence of hydrophobic amino acids, which cells (4,5). These data indicate that cell surface heparan are absent in TAT-PTD and poly-arginine PTDs. Theresulfate proteoglycans are thus required for PDX-1 interfore, such a mechanism is unlikely to be a common PTD nalization.
delivery mechanism. A third model is endocytosis followed by passage from the vesicle into the cytoplasm; DISCUSSION although this implies vesicle disruption, the plasma Recent reports detail the various mechanisms of promembrane and cell viability are not affected. Some studtein transduction. One model describes the internalizaies have shown that TAT-PTD, polyR-PTD, Antp-PTD, and arginine-rich peptide SynB enter cells by endocytosis rather than by temperature-or energy-independent translocation (3,28). The real-time observation of protein transduction in the previous study showed that Antp-PTD, TAT-PTD, 11R-PTD, PDX-1, and BETA2/ NeuroD transcription factor penetrates into cells by macropinocytosis, a type of endocytosis, and is released from the endosome homogeneously into the cytoplasm and nuclei (7, 18, 20, 22) . A number of well-characterized toxins reach the cytosol of eukaryotic cells after binding to the cell surface, undergoing endocytosis and retrograde transport to the Golgi apparatus and endoplasmic reticulum (13, 32) . PDX-1 protein transports by a similar mechanism to that of these protein toxins.
This study examined whether cell surface heparan sulfate proteoglycans mediate PDX-1 internalization using soluble GAGs, GAG lyases, and different mutant 
